How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,599 results for

Polypharmacy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Polypharmacy

Polypharmacy Polypharmacy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Polypharmacy Polypharmacy Aka: Polypharmacy II. Definition (...) Polypharmacy Too many medications or use of unnecessary drugs Five or more medications used empirically III. Epidemiology Patients over age 65 years consume one third of all medications in the United States Average patient uses 4 perscribed medications and at least one OTC medication IV. Precautions Polypharmacy leads to increased adverse drug events (ADEs) including s See See See Patients on 2 drugs have a 35% risk of ADE, while those on >6 drugs have an 82% ADE risk Adverse drug events are among the top

2018 FP Notebook

262. Health consequences of polypharmacy among adults in South Asia - a systematic review protocol

Health consequences of polypharmacy among adults in South Asia - a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

263. Patient experience and self-management of polypharmacy: a meta-ethnography

Patient experience and self-management of polypharmacy: a meta-ethnography Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

264. Prevalence, risk factors and health consequences of polypharmacy among adults in South Asia: a systematic review protocol

Prevalence, risk factors and health consequences of polypharmacy among adults in South Asia: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

265. Interventions to manage or reduce polypharmacy in adults with chronic conditions: a review of reviews

Interventions to manage or reduce polypharmacy in adults with chronic conditions: a review of reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

266. Prevalence of polypharmacy among adults in South Asia: a systematic review

Prevalence of polypharmacy among adults in South Asia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

267. Polypharmacy interventions in older adults and impact on mobility: systematic review

Polypharmacy interventions in older adults and impact on mobility: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

268. Pharmaceutical interventions in community pharmacies (health primary care) that reduce polypharmacy-associated risks in elders over 65 years: overview

Pharmaceutical interventions in community pharmacies (health primary care) that reduce polypharmacy-associated risks in elders over 65 years: overview Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

269. Efficacy and safety outcomes of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation on amiodarone or polypharmacy: systematic review and meta-analysis

Efficacy and safety outcomes of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation on amiodarone or polypharmacy: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2018 PROSPERO

270. Systematic review of controlled trials of combined pharmacotherapy (polypharmacy) for children and adolescents

Systematic review of controlled trials of combined pharmacotherapy (polypharmacy) for children and adolescents Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

271. What adverse outcomes are associated with polypharmacy in later life? A systematic review of reviews

What adverse outcomes are associated with polypharmacy in later life? A systematic review of reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

272. A review of patient decision aids in older people to address polypharmacy

A review of patient decision aids in older people to address polypharmacy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

273. Comorbidity-Polypharmacy Score as Predictor of Outcomes in Older Trauma Patients: A Retrospective Validation Study (Abstract)

Comorbidity-Polypharmacy Score as Predictor of Outcomes in Older Trauma Patients: A Retrospective Validation Study Traditional injury severity assessment is insufficient in estimating the morbidity and mortality risk for older (≥45 years) trauma patients. Commonly used tools involve complex calculations or tables, do not consider all comorbidities, and often rely on data that are not available early in the trauma patient's hospitalization. The comorbidity-polypharmacy score (CPS), a sum of all

2015 EvidenceUpdates

274. Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults

Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults Top 10 most read in October: Physician-pharmaceutical industry interactions, systematic reviews and unpublished data, and polypharmacy and falls in older adults | BMJ Open by Four new entries, and two re-entries, made it into BMJ Open’s top 10 most read articles in October. Climbing back into the top position is a longitudinal cohort (...) for it. Dhalwani et al. are new in at number eight. Using data from The English Longitudinal Study of Ageing the researchers examine the association between polypharmacy and falls in older adults. The rate of falls was found to be 21% higher in people with polypharmacy (five or more drugs) than those without. The final new entry for October is at number 9; Firmino-Machado et al. report the protocol for an ongoing population-based randomised controlled trial to improve Cervical Cancer Screening Adherence. Rank

2017 BMJ Open Blog

275. Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit. Full Text available with Trip Pro

Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit. Polypharmacy and inappropriate medication prescriptions are associated with increased morbidity and mortality. Most interventions proposed to improve appropriate prescribing are time and resource intensive and therefore hardly applicable in daily clinical practice.To test the efficacy of an easy-to-use checklist aimed at supporting the therapeutic reasoning (...) of potentially inappropriate medications (PIMs) at discharge, according to STOPP criteria, and the number of prescribed medications at discharge, before and after the introduction of the checklist. Secondary outcomes were the prevalence of polypharmacy (≥ 5 drugs) and hyperpolypharmacy (≥ 10 drugs), and the prevalence of potentially inappropriate prescribing omissions (PPOs) according to START criteria.At admission 59% of the 900 patients were taking > 5 drugs, 13% ≥ 10 drugs, 37% had ≥ 1 PIM and 25% ≥ 1 PPO

2016 PLoS ONE

276. [Antipsychotic polypharmacy in the treatment of schizophrenia]

[Antipsychotic polypharmacy in the treatment of schizophrenia] Antipsykotisk polyfarmaci i behandlingen af skizofreni [Antipsychotic polypharmacy in the treatment of schizophrenia] Antipsykotisk polyfarmaci i behandlingen af skizofreni [Antipsychotic polypharmacy in the treatment of schizophrenia] Baandrup L, Lublin H, Nordentoft M, Peacock L, Sorensen J, Andersen SE, Glenthoj B Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation Baandrup L, Lublin H, Nordentoft M, Peacock L, Sorensen J, Andersen SE, Glenthoj B. Antipsykotisk polyfarmaci i behandlingen af skizofreni. [Antipsychotic polypharmacy in the treatment of schizophrenia] Copenhagen: Danish Centre for Evaluation and Health Technology Assessment (DACEHTA). Volume 11(1). 2011 Authors' objectives The aim of this health technology assessment is to explore how antipsychotic polypharmacy

2011 Health Technology Assessment (HTA) Database.

277. Understanding the association between antipsychotic polypharmacy and metabolic disorders in people with psychosis

Understanding the association between antipsychotic polypharmacy and metabolic disorders in people with psychosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

278. Polypharmacy associated with non-prescribed medicines use among older adults with multi-morbidity: a systematic review

Polypharmacy associated with non-prescribed medicines use among older adults with multi-morbidity: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

279. Systematic review of polypharmacy tools and association with clinical outcomes

Systematic review of polypharmacy tools and association with clinical outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

280. Who’s responsible for polypharmacy in the elderly?

Who’s responsible for polypharmacy in the elderly? Who's responsible for polypharmacy in the elderly? Who’s responsible for polypharmacy in the elderly? | | November 20, 2017 211 Shares There’s a common affliction that’s rampant in my practice, but it’s not a gastrointestinal condition. It’s called polypharmacy, and it refers to patients who are receiving a pile of prescription and other medications. I see this daily in the office and in the hospital. It’s common enough to see patients who (...) are receiving 10 or more medications, usually from 3 or 4 medical specialists. Of course, every doctor feels that he is prescribing only what is truly necessary. If an individual has an internist, a cardiologist, a gastroenterologist, a urologist and a dermatologist — which is not unusual — and each prescribes only 2 or 3 essential medicines, then polypharmacy is created. Each day, the patient swallows a chemistry set. First of all, I don’t know how these patients, who are often elderly, manage

2017 KevinMD blog

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>